There is zero epidemiological evidence of increased risk of breast cancer in MtFs (in the U.S.). From what several trans-specializing MDs with patient loads in above 1000 have told me, there is surprisingly little risk in their patient groups.
The point is we do not know what trans folks as a population get sick and die of, which is a tragedy, precisely because the data are not collected. That must change. (Aside: MDs also need to get comfortable saying “I don’t know” and “We don’t know,” instead of spouting of things that sound good at the time. Trans folks deserve better.)
